Facial expressivity in the course of schizophrenia and depression

European Archives of Psychiatry and Clinical Neuroscience
W Gaebel, Wolfgang Wölwer

Abstract

This study investigates the nosological specificity and time stability of reduced facial expressivity in schizophrenia by means of objective measurement. Facial expression in an emotional interview was evaluated using the "Facial Action Coding System" in 33 acute schizophrenia patients and 23 acute depressive patients in comparison with 21 nonpatient controls, each assessed twice within 4 weeks, and in 36 partly remitted schizophrenia patients assessed twice within 3 months. Acute schizophrenia patients showed reduced facial activity especially in the upper face and in facial activity often used as communicative signs or as signs of positive emotions. As depressive patients showed a comparable pattern of facial activity, nosological specificity is questionable. This pattern remained stable in the acute illness course and was almost identical in remitted schizophrenia patients, indicating a marked time stability of attenuated facial expressivity in schizophrenia and--for the acute phase assessed--in depression.

Citations

Dec 12, 2007·European Archives of Psychiatry and Clinical Neuroscience·Georg JuckelU Hegerl
Oct 10, 2009·European Archives of Psychiatry and Clinical Neuroscience·Gwenda SimonsWolfgang Wölwer
Oct 20, 2012·European Archives of Psychiatry and Clinical Neuroscience·Katharina DruschWolfgang Wölwer
Dec 15, 2012·European Archives of Psychiatry and Clinical Neuroscience·Annett LotzinBrigitte Ramsauer
Jun 19, 2008·Brain : a Journal of Neurology·Andréy MazaratiRaman Sankar
Jun 27, 2008·Schizophrenia Bulletin·Ann M Kring, Erin K Moran
Sep 12, 2012·Schizophrenia Research and Treatment·H Fatouros-BergmanA Werbart
Feb 12, 2011·Journal of Personality Disorders·Swantje MatthiesAlexandra Philipsen
Apr 12, 2014·Schizophrenia Research and Treatment·Jihun HammChristian G Kohler
Sep 17, 2008·Schizophrenia Research·Christian G KohlerRuben C Gur
Sep 16, 2008·Schizophrenia Research·Christian G KohlerRuben C Gur
Dec 26, 2006·Progress in Neuro-psychopharmacology & Biological Psychiatry·Alfonso TroisiAlessandro Sterpone
Nov 1, 2006·Psychiatry Research·Barbara L SchwartzStephen I Deutsch
Nov 23, 2007·Depression and Anxiety·Francisco Pedrosa GilMarius Nickel
Nov 20, 2008·Depression and Anxiety·Francisco Pedrosa GilMarius Nickel
Nov 26, 2013·Schizophrenia Research·Jung Suk LeeJae-Jin Kim
Apr 26, 2016·Psychiatry Research·Timothy R CampelloneAnn M Kring
Dec 6, 2014·Computational and Mathematical Methods in Medicine·Peng WuMarie Vandekerckhove
Nov 8, 2014·Image and Vision Computing·Jeffrey M GirardDean P Rosenwald
May 22, 2010·Schizophrenia Research·Kristin M HealeyChristian G Kohler
Jun 22, 2006·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Karsten WolfDieter Naber
Nov 2, 2018·European Psychiatry : the Journal of the Association of European Psychiatrists·Janina RichterStefan Klingberg
Sep 4, 2012·Schizophrenia Bulletin·Mary LavelleRosemarie McCabe
Nov 10, 2020·Psychological Medicine·Aleks StolicynPeggy Seriès
Apr 17, 2008·The Journal of Nervous and Mental Disease·Martin BrüneAlfonso Troisi
Jan 1, 2014·The Journal of Nervous and Mental Disease·Mary LavelleRosemarie McCabe
May 9, 2021·Schizophrenia Bulletin·Tina GuptaVijay A Mittal
Jul 3, 2021·Brain Sciences·Francesco PancottiLaila Craighero
Sep 21, 2021·Frontiers in Psychology·Wenhua YanLiangliang Chen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.